ArticleFrontiers in cardiovascular medicine2026
Case Report: Ultrasound-guided thrombin injection for the treatment of radial artery pseudoaneurysm after percutaneous coronary intervention.
Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Radial artery pseudoaneurysm (RAP) is an uncommon but significant complication after transradial coronary procedures. This case demonstrates the efficacy of ultrasound-guided thrombin injection (UGTI) as a minimally invasive treatment. Case presentation: A 65-year-old Chinese male developed a RAP two days after percutaneous coronary intervention. Diagnosis was confirmed by Doppler ultrasound. UGTI was performed, injecting 1.5 mL of thrombin. Complete thrombosis occurred within 30 s, with sustained occlusion confirmed at 24-hour follow-up. Conclusions: UGTI is a highly effective and safe first-line treatment for iatrogenic RAP, enabling rapid resolution and avoiding the need for surgery. It represents a superior minimally invasive strategy for managing this vascular complication.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.